Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

OORAMED PHARMACEUTICALS INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
O

ORAMED PHARMACEUTICALS INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions

News

News

  • Comment on Oramed Reaches 50% Enrollment in its Second Phase 3 Oral Insulin Trial by luckywin777app
    Sep 25, 2026Comments for Oramed Pharmaceuticals

    Just downloaded the luckywin777app. The interface is smooth, and they have a good variety of games. Hopefully, the name is true. Wish me luck! You can try it yourself here <a href="https://luckywin777app.com" rel="nofollow ugc">luckywin777app</a>

  • Comment on Seeking Alpha: Oramed inks contract with Medicox to distribute oral insulin in South Korea by affun
    Sep 24, 2026Comments for Oramed Pharmaceuticals

    Gave affun a whirl last night. Had a good time! Some unique games I hadn't seen before. Worth a look if you're looking for something different. <a href="https://affun.net" rel="nofollow ugc">affun</a>

  • Comment on Oramed Pharmaceuticals Issues Shareholder Update by Get4Games
    Jul 11, 2026Comments for Oramed Pharmaceuticals

    Genel hatlarıyla faydalı bir yazı.

  • Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
    Jun 25, 2026Press Releases – Oramed Pharmaceuticals

    Significant Appreciation in Alpha Tau (NASDAQ: DRTS) Position (up ~$128 Million) Scilex (NASDAQ: SCLX) Loan Substantially Repaid Total Cash and Assets Build to Approximately $270 Million (as of March 31, 2026, after the $10.5 million dividend paid in January 2026) Oramed to Join the Russell 2000 and Russell 3000 Indexes this week NEW YORK, June 25, 2026 /PRNewswire/ — Oramed […]

  • Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
    Jun 25, 2026Oramed Pharmaceuticals

    Significant Appreciation in Alpha Tau (NASDAQ: DRTS) Position (up ~$128 Million) Scilex (NASDAQ: SCLX) Loan Substantially Repaid Total Cash and Assets Build to Approximately $270 Million (as of March 31, 2026, after the $10.5 million dividend paid in January 2026) Oramed to Join the Russell 2000 and Russell 3000 Indexes this week NEW YORK, June 25, 2026 /PRNewswire/ — Oramed […]

  • Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes
    Jun 17, 2026Press Releases – Oramed Pharmaceuticals

    NEW YORK, June 17, 2026 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), announced today that it is set to join the U.S. small cap Russell 2000® and broad-market Russell 3000® Index at the conclusion of the 2026 Russell indexes semi-annual reconstitution. The 2026 Russell 2000 and Russell 3000 reconstitution becomes final after the close of US markets on […]

  • Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes
    Jun 17, 2026Oramed Pharmaceuticals

    NEW YORK, June 17, 2026 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), announced today that it is set to join the U.S. small cap Russell 2000® and broad-market Russell 3000® Index at the conclusion of the 2026 Russell indexes semi-annual reconstitution. The 2026 Russell 2000 and Russell 3000 reconstitution becomes final after the close of US markets on […]

  • Comment on Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock by Alina927
    Apr 24, 2026Comments for Oramed Pharmaceuticals

    <a href="https://shorturl.fm/OqdmY" rel="nofollow ugc">https://shorturl.fm/OqdmY</a>

  • Comment on Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt by Krystal885
    Apr 24, 2026Comments for Oramed Pharmaceuticals

    <a href="https://shorturl.fm/tPpzl" rel="nofollow ugc">https://shorturl.fm/tPpzl</a>

  • Comment on Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin by Bobby1002
    Apr 24, 2026Comments for Oramed Pharmaceuticals

    <a href="https://shorturl.fm/CXaVJ" rel="nofollow ugc">https://shorturl.fm/CXaVJ</a>

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions
$4.75Close · Sep 22, 2026